Overview

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of azelaic acid (AzA) foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea compared to its vehicle.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid